Healthcare - Biotechnology - NASDAQ - US
$ 29.54
-4.23 %
$ 4.6 B
Market Cap
-295.4
P/E
Price Target
Average
39.92%
Revenue Forecast
Estimate
52.83%
EBIT
Estimate
--164.66%
Net Income
Estimate
160.92%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
TG Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for TGTX of $41.3 , with forecasts ranging from a low of $20 to a high of $55 .
TGTX Lowest Price Target
Wall Street Target
20 USD
-32.30%
TGTX Average Price Target
Wall Street Target
41.3 USD
39.92%
TGTX Highest Price Target
Wall Street Target
55 USD
86.19%
REVENUE FORECAST
Revenue Forecast Chart TGTX
EBIT FORECAST
EBIT Forecast Chart TGTX
NET INCOME FORECAST
Net Income Chart TGTX